Valued at USD 5.10 Billion in 2024, the global antisense and RNAi therapeutics market is expanding due to growing investments in genetic research and rising genetic disorders. Forecasted to grow at a CAGR of 18.70% during 2025-2034, the market is likely to reach USD 28.32 Billion by 2034, driven by innovation and clinical adoption. https://www.expertmarketresearch.com/reports/antisense-and-rnai-therapeutics-market